Last reviewed · How we verify
NCT07373002
Development and Evaluation of an Intelligent Parent-Infant Connection-Based Intervention to Strengthen Family Resilience in Preterm Infant Care
NA trial testing Intelligent Intervention to enhance Parent-Infant Connection and Family Resilience in Family Resilience in 300 participants. Not yet recruiting.
31 July 2027
Quick facts
| Lead sponsor | National Defense Medical Center, Taiwan |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 300 |
| Start date | 1 April 2026 |
| Primary completion | 31 July 2027 |
| Estimated completion | 31 July 2029 |
Drugs / interventions tested
- Intelligent Intervention to enhance Parent-Infant Connection and Family Resilience
- Routine Care
Conditions studied
- Family Resilience — all drugs for Family Resilience →
- Parent-Infant Bonding — all drugs for Parent-Infant Bonding →
- Parents of Premature Infants — all drugs for Parents of Premature Infants →
- Intelligent Intervention — all drugs for Intelligent Intervention →
Sponsor
National Defense Medical Center, Taiwan
Who can join
Adults 18 to 80, any sex, with Family Resilience or Parent-Infant Bonding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to develop, optimize, and evaluate the effectiveness of a family resilience intervention centered on intelligent parent-infant connection for parents of preterm infants. Using a longitudinal randomized controlled trial design, it examines the intervention's impact on parental psychosocial health, parenting efficacy, family resilience, and parent-infant interaction from NICU hospitalization to six months post-discharge.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07373002
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Family Resilience
Currently open trials in the same condition.
- NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
Other National Defense Medical Center, Taiwan trials
Trials by the same sponsor.
- NCT07488052 — Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG) · recruiting
- NCT07307729 — AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emu · NA · not yet recruiting
- NCT07217236 — Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG · NA · recruiting
- NCT06887699 — The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value- · NA · recruiting
- NCT06847932 — Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07373002 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Defense Medical Center, Taiwan
- Last refreshed: 28 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07373002.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing